We are live on ! Find out more
VIVO

Meridian Bioscience Inc
VIVO

Delisted

VIVO was delisted on the 30th of January, 2023.

Back to rankings

177 hedge funds and large institutions have $592M invested in Meridian Bioscience Inc in 2018 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 60 increasing their positions, 62 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

684% more call options, than puts

Call options by funds: $1.31M | Put options by funds: $167K

13% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 16

0% more funds holding

Funds holding: 177 → 177 (0)

3% less repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 62

4% less capital invested

Capital invested by funds: $615M → $592M (-$22.8M)

Holders
177
Holders Change
–
Holders Change %
0%
% of All Funds
4.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
60
Reduced
62
Closed
16
Calls
$1.31M
Puts
$167K
Net Calls
+$1.14M
Net Calls Change
-$704K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$5.08M
2
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$4.48M
3
Invesco
Invesco
Georgia
+$4.24M
4
Morgan Stanley
Morgan Stanley
New York
+$2.97M
5
Renaissance Technologies
Renaissance Technologies
New York
+$2.63M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$2.6M
2
Citadel Advisors
Citadel Advisors
Florida
-$2.2M
3
Prudential Financial
Prudential Financial
New Jersey
-$2.05M
4
Deutsche Bank
Deutsche Bank
Germany
-$1.93M
5
CS
Credit Suisse
Switzerland
-$1.58M
Name Holding Trade Value Shares
Change 		Change in
Stake
ECM
126
Element Capital Management
New York
$221K +$230K +14,863 New
JG
127
Jefferies Group
New York
$217K +$225K +14,539 New
MLICM
128
Metropolitan Life Insurance Company (MetLife)
New York
$213K – – –
Bank of America
129
Bank of America
North Carolina
$196K -$125K -8,069 -38%
MSA
130
Mason Street Advisors
Wisconsin
$187K +$5.18K +334 +3%
BCM
131
BlueCrest Capital Management
Jersey
$179K +$186K +11,998 New
CCIA
132
Campbell & Co Investment Adviser
Maryland
$168K +$175K +11,266 New
RS
133
Robeco Schweiz
Switzerland
$153K +$105K +6,800 +194%
COPPSERS
134
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$151K +$157K +10,121 New
CBB
135
Citizens Business Bank
California
$149K – – –
CAPTRUST Financial Advisors
136
CAPTRUST Financial Advisors
North Carolina
$134K +$139K +8,960 New
First Manhattan
137
First Manhattan
New York
$105K – – –
BCWM
138
Bartlett & Co Wealth Management
Ohio
$72.1K – – –
BC
139
Bartlett & Co
Ohio
$72K – – –
AIP
140
Ameritas Investment Partners
Nebraska
$53K – – –
Zurich Cantonal Bank
141
Zurich Cantonal Bank
Switzerland
$52K – – –
US Bancorp
142
US Bancorp
Minnesota
$38K +$18.6K +1,200 +86%
BNP Paribas Financial Markets
143
BNP Paribas Financial Markets
France
$37.5K -$68.9K -4,444 -64%
RFM
144
Royal Fund Management
Florida
$33K – – –
PK
145
Pflug Koory
Nebraska
$32K -$3.1K -200 -9%
AIM
146
Arcadia Investment Management
Michigan
$30K – – –
SWM
147
SeaCrest Wealth Management
New York
$27K – – –
Walleye Trading
148
Walleye Trading
New York
$27K +$27.9K +1,800 New
Fuller & Thaler Asset Management
149
Fuller & Thaler Asset Management
California
$25K – – –
LIA
150
LS Investment Advisors
Michigan
$21K – – –
4 5
6
7 8

VIVO Hedge Fund Activity: Q3 2018 in Review

177 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q3 2018, worth a combined $592M — down 3.7% from $615M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new VIVO positions and 16 closed out — a net gain of 2 holders — while 60 added to existing stakes and 62 trimmed.

The largest buyer was BlackRock, adding an estimated $5.08M. The largest seller was Millennium Management, cutting an estimated $2.6M.

  • 177 institutional investors held Meridian Bioscience Inc (VIVO) as of Q3 2018, unchanged from Q2 2018.
  • Funds reported $592M of Meridian Bioscience Inc stock for Q3 2018, down 3.7% quarter-over-quarter.
  • 18 funds opened new Meridian Bioscience Inc positions in Q3 2018 and 16 closed out, a net change of +2 holders.
  • The largest Meridian Bioscience Inc buyer in Q3 2018 was BlackRock, an estimated $5.08M added.
  • The largest Meridian Bioscience Inc seller in Q3 2018 was Millennium Management, an estimated $2.6M sold.

Based on aggregated 13F filings for Q3 2018.